# American Healthcare REIT, Inc.: filings

AHR · NYSE · CIK 1632970 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ahr.md) · [Financials](/companies/ahr/financials.md) · [Filings](/companies/ahr/filings.md) · [Insiders](/companies/ahr/insiders.md)

## Reports and events: 279 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 390, 8-K 217, 10-Q 32, 3 20, 424B3 17, EFFECT 16, CORRESP 15, POS AM 13, 10-K 11, 144 11, 425 11, SCHEDULE 13G/A 11, 424B5 10, UPLOAD 10, 8-K/A 9, DEF 14A 9, S-11/A 8, DEFA14A 4, SC 13G 4, 5 3, POS EX 3, FWP 2, S-11 2, S-8 2, SC 13G/A 2, SCHEDULE 13G 2, 10-Q/A 1, 424B2 1, 424B4 1, 4/A 1, 8-A12B 1, 8-A12G 1, CERT 1, DRS 1, DRS/A 1, DRSLTR 1, S-3ASR 1, S-3D 1, S-4 1, S-4/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-18 | 20:25 ET | [8-K](/filings/0001193125-26-395604.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-395604 |
| 2026-09-14 | 10:35 ET | [8-K](/filings/0001193125-26-389802.md) | 7.01 Regulation FD disclosure | 0001193125-26-389802 |
| 2026-09-02 | 21:22 ET | [8-K](/filings/0001193125-26-380473.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-380473 |
| 2026-09-01 | 20:29 ET | [8-K](/filings/0001193125-26-378483.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-378483 |
| 2026-08-24 | 20:16 ET | [8-K](/filings/0001193125-26-363616.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-363616 |
| 2026-08-12 | 20:16 ET | [8-K](/filings/0001193125-26-346895.md) | 8.01 Other events | 0001193125-26-346895 |
| 2026-08-10 | 20:06 ET | [8-K](/filings/0001193125-26-342358.md) | 1.01 Entry into a material agreement | 0001193125-26-342358 |
| 2026-08-07 | 20:15 ET | [10-Q](/filings/0001193125-26-340269.md) | Quarterly report, period 2026-06-30 | 0001193125-26-340269 |
| 2026-08-06 | 20:17 ET | [8-K](/filings/0001193125-26-338076.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-338076 |
| 2026-07-22 | 20:16 ET | [8-K](/filings/0001193125-26-312419.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-312419 |
| 2026-06-25 | 20:29 ET | [8-K](/filings/0001193125-26-282860.md) | 5.07 Shareholder vote results | 0001193125-26-282860 |
| 2026-06-18 | 20:16 ET | [8-K](/filings/0001193125-26-275899.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-275899 |
| 2026-05-28 | 20:16 ET | [8-K](/filings/0001193125-26-245272.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-245272 |
| 2026-05-22 | 20:15 ET | [8-K](/filings/0001193125-26-236930.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-236930 |
| 2026-05-08 | 20:16 ET | [10-Q](/filings/0001193125-26-214678.md) | Quarterly report, period 2026-03-31 | 0001193125-26-214678 |
| 2026-05-07 | 20:20 ET | [8-K](/filings/0001193125-26-212023.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-212023 |
| 2026-04-09 | 20:18 ET | [DEF 14A](/filings/0001193125-26-149677.md) | Proxy statement, period 2026-04-09 | 0001193125-26-149677 |
| 2026-04-07 | 20:39 ET | [8-K](/filings/0001193125-26-145647.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-145647 |
| 2026-03-24 | 20:26 ET | [8-K/A](/filings/0001193125-26-121898.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-121898 |
| 2026-03-18 | 20:16 ET | [8-K](/filings/0001193125-26-114004.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-114004 |
| 2026-02-27 | 22:24 ET | [8-K](/filings/0001193125-26-083247.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-083247 |
| 2026-02-27 | 21:17 ET | [10-K](/filings/0001193125-26-082692.md) | Annual report, period 2025-12-31 | 0001193125-26-082692 |
| 2026-02-26 | 21:20 ET | [8-K](/filings/0001193125-26-076786.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-076786 |
| 2026-02-04 | 21:32 ET | [8-K](/filings/0001193125-26-037696.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-037696 |
| 2025-12-16 | 21:16 ET | [8-K](/filings/0001193125-25-320892.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-320892 |
| 2025-11-26 | 21:16 ET | [8-K](/filings/0001193125-25-300540.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-300540 |
| 2025-11-24 | 21:16 ET | [8-K](/filings/0001193125-25-293711.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-293711 |
| 2025-11-07 | 21:16 ET | [10-Q](/filings/0001193125-25-272390.md) | Quarterly report, period 2025-09-30 | 0001193125-25-272390 |
| 2025-11-06 | 22:07 ET | [8-K](/filings/0001193125-25-270069.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-270069 |
| 2025-09-18 | 20:35 ET | [8-K](/filings/0001193125-25-207494.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-207494 |
| 2025-08-08 | 20:20 ET | [10-Q](/filings/0001632970-25-000064.md) | Quarterly report, period 2025-06-30 | 0001632970-25-000064 |
| 2025-08-08 | 20:17 ET | [8-K](/filings/0001632970-25-000063.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001632970-25-000063 |
| 2025-08-07 | 20:18 ET | [8-K](/filings/0001632970-25-000057.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001632970-25-000057 |
| 2025-06-26 | 20:22 ET | [8-K](/filings/0001632970-25-000050.md) | 5.07 Shareholder vote results | 0001632970-25-000050 |
| 2025-06-20 | 20:16 ET | [8-K](/filings/0001632970-25-000046.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001632970-25-000046 |
| 2025-05-09 | 20:19 ET | [10-Q](/filings/0001632970-25-000042.md) | Quarterly report, period 2025-03-31 | 0001632970-25-000042 |
| 2025-05-09 | 01:52 ET | [8-K/A](/filings/0001632970-25-000040.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001632970-25-000040 |
| 2025-05-08 | 20:18 ET | [8-K](/filings/0001632970-25-000037.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001632970-25-000037 |
| 2025-04-10 | 20:15 ET | [DEF 14A](/filings/0001632970-25-000027.md) | Proxy statement, period 2025-04-10 | 0001632970-25-000027 |
| 2025-03-19 | 21:05 ET | [8-K](/filings/0001632970-25-000021.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001632970-25-000021 |
| 2025-02-28 | 21:57 ET | [10-K](/filings/0001632970-25-000018.md) | Annual report, period 2024-12-31 | 0001632970-25-000018 |
| 2025-02-27 | 21:16 ET | [8-K](/filings/0001632970-25-000013.md) | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001632970-25-000013 |
| 2025-02-24 | 21:22 ET | [8-K](/filings/0001632970-25-000006.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001632970-25-000006 |
| 2024-12-18 | 21:18 ET | [8-K](/filings/0001632970-24-000134.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001632970-24-000134 |
| 2024-11-18 | 14:17 ET | [8-K](/filings/0001632970-24-000125.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001632970-24-000125 |
| 2024-11-13 | 19:01 ET | [10-Q](/filings/0001632970-24-000121.md) | Quarterly report, period 2024-09-30 | 0001632970-24-000121 |
| 2024-11-12 | 21:17 ET | [8-K](/filings/0001632970-24-000119.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001632970-24-000119 |
| 2024-11-08 | 21:21 ET | [8-K](/filings/0001632970-24-000114.md) | 5.07 Shareholder vote results | 0001632970-24-000114 |
| 2024-09-20 | 20:15 ET | [8-K](/filings/0001632970-24-000106.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001632970-24-000106 |
| 2024-09-06 | 20:15 ET | [8-K](/filings/0001632970-24-000101.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001632970-24-000101 |

Page 1 of 6. [Older](/companies/ahr/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.